Erythromycin Capsule, Delayed Release Pellets
Product Images NDC 75907-076

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 75907-076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Labratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Eryc 01)

Chemical structure of erythromycin, showing the detailed molecular arrangement including carbon, hydrogen, nitrogen, and oxygen atoms. The molecular formula C37H37NO13 and the molecular weight 733.94 are depicted below the structure.*

FDA Label Image

Pdp-250mg Capsule Bottle Label (Eryc 02)

Label for erythromycin delayed-release capsules, USP, 250 mg strength. The label states each capsule contains 250 mg erythromycin base as enteric-coated pellets. It is produced by Dr. Reddy's Laboratories Inc. and contains 100 capsules. Storage instructions and usual adult dosage reference are included, along with a barcode and contact information for the distributor.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.